Skip to content

NB PHARMA

Active Private limited companyfounded 1999active for 27 yearsAlbert I laan 255, 8620 NieuwpoortKBO/BCE: BE 0465.917.724 subsidiary of SODIAP
Part of the group 42 companies

Lifetime

20 annual accounts with figures on one time axis, 27 filings since 2000
peak of €296,749 in 2024
€272,272▼ 8.2%
lowest -€22,330 in 31-12-2020
€56,725▲ 19.3%
peak of €573,958 in 2025
€573,958▲ 11.0%
€171,581▲ 11.7%
peak of 2.6 FTE in 2024
1.8 FTE▼ 30.8%
Board7 names since 2020
2 directors and 1 other
Owners
100%
Documentsfilings and deeds
12-05-202680 days before the deadline
2025abbreviated format
Staff from 2.6 FTE to 1.8 FTECash from €8,387 to €13,228

Key points

from the 2025 annual accounts

Equity

€573,958 ▲ 11.0%

NB PHARMA has made a profit without a break since 2022.

Turnover

≈ €940,000 estimated

The accounts state no turnover.

Staff

2 employees on 31-12-2025
302023112024452025

In 2025, 4 employees joined and 5 left.

Filings

26 annual accounts 27 filings since 2000
AprilJune31 JulyOctober200020102020

The last five annual accounts were filed 44 to 80 days before the end of the period.

Board

1 joined

New director. Latest change 19-05-2026 · 3 in office.

Position in the sector

77.0%

Higher solvency than 87% of companies in retail trade. Sector median 36.9% · 13,267 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 31,389 companies had the same profile as NB PHARMA has now. Each dot stands for 79 companies, two years later.

93.4%
were still trading
6.0%
stopped another way
0.5%
went bankrupt
  • Micro
  • 20 years or older
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more

Another 0.1% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 497,962 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 31,389 companies, not a prediction for NB PHARMA. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Chair,
Managing director,
Director,
  • 100%score equity €33.0m (2025) · annual accounts 2025 of SODIAP
Board & ownership

Recent changes

1 director appointed, 1 resignation, 1 reappointment resigns · , and act as permanent representatives · appointed · General meeting of 19-05-2026 · Gazette deed
Registered in the Peppol Directory Reachable for e-invoices through 0208:0465917724
Transfer: Sodiap transfers a branch of activity to NB Pharma Registered office moved from Izegem to Nieuwpoort · Issue of 56,349 shares · The registered office moved from Noordkaai 9, 8870 Izegem to Albert I-laan 255, 8620 Nieuwpoort · General meeting of 28-06-2023 · Gazette deed
Transfer proposal: Sodiap BV transfers a branch of activity to NB Pharma and act as permanent representatives · holds 28,500 shares (100%) · Sodiap BV holds 15,000 shares (100%) · Gazette deed
All 44 events

Comparable companies

same main activity, similar in size and age
Company
NB PHARMA Nieuwpoort €745,538 €272,272 77.0% 1.8
APOTHEEK DECLERCK Kortrijk €790,903 €278,652 58.4% 2.1
APOTHEEK OPWIJK LENAERTS Opwijk €697,583 €273,194 14.4% 1.8
FARMAPUNT ACHEL Hamont-Achel €721,434 €291,653 60.5% 2
Apotheek Daenen Rotselaar €822,691 €261,168 43.7% 1.8
D'HUYVETTER - VANDERMARLIERE Zulte €737,810 €244,606 78.0% 1.7
APOTHEEK DEFAUW FRANK Roeselare €680,611 €274,503 43.0% 1.8

These companies have the same main activity as NB PHARMA: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €681,000 and €823,000, founded between 1996 and 2003.

Official details

Source: KBO
Status
Active since 20-04-1999Normal situation
Activity
Retail sale of pharmaceutical productsNACE 47730
Joint committee
313Pharmacies and pricing offices · annual accounts 2025
Establishment unit
2.092.324.9398620 Nieuwpoort, registered on 29-09-1999
Financial year end
31 December
Peppol
Reachable since 06-06-2025
Company details

Annual accounts 2025

€745,538▲ 11.1%
Employeeson 31-12-2025
2▼ 33.3%
Filing
Filed on 12-05-2026, 80 days before the end of the filing period
Financials

Companies linked to NB PHARMA

Parent and group

Insights on NB PHARMA

NB PHARMA files the abbreviated format. That format states no turnover. The gross margin rose from €92,731 in 2007 to €272,272 in 2025.

SODIAP holds all the shares.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about NB PHARMA

What is the company number of NB PHARMA?
The company number of NB PHARMA is 0465.917.724. The VAT number is the same number with BE in front: BE 0465.917.724.
Where is NB PHARMA based?
The registered office is at Albert I laan 255, 8620 Nieuwpoort.Company details
What does NB PHARMA do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of NB PHARMA?
NB PHARMA is a private limited company (BV).
When was NB PHARMA founded?
NB PHARMA was founded on 20-04-1999.
Is NB PHARMA still active?
Yes, NB PHARMA is an active enterprise in the KBO register.
How many employees does NB PHARMA have?
NB PHARMA had an average of 1.8 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
Which joint committee does NB PHARMA fall under?
In its 2025 annual accounts, NB PHARMA states joint committee 313 (Pharmacies and pricing offices).
What is the turnover of NB PHARMA?
The turnover in financial year 2025 is ≈ €940,000. This figure is estimated from the gross margin of €272,272 and 42 comparable companies (NACE 477). It probably lies between €740,000 and €1.3m.
Is NB PHARMA profitable?
In financial year 2025, NB PHARMA made a profit of €56,725.
Where can I find the annual accounts of NB PHARMA?
NB PHARMA filed 27 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of NB PHARMA due?
NB PHARMA must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.